Abstract:BackgroundHuman pluripotent stem cells (hPSCs) provide a promising cell source for ocular cell replacement therapy, but often lack standardized and xenogeneic-free culture and differentiation protocols. We aimed to develop a xeno- and feeder cell-free culture system for undifferentiated hPSCs along with efficient methods to derive ocular therapy target cells: retinal pigment epithelial (RPE) cells and corneal limbal epithelial stem cells (LESCs).MethodsMultiple genetically distinct hPSC lines were adapted to a defined, xeno-, and feeder-free culture system of Essential 8™ medium and laminin-521 matrix. Thereafter, two-stage differentiation methods toward ocular epithelial cells were established utilizing xeno-free media and a combination of extracellular matrix proteins. Both differentiation methods shared the same basal elements, using only minor inductive modifications during early differentiation towards desired cell lineages. The resulting RPE cells and LESCs were characterized after several independent differentiation experiments and recovery after xeno-free cryopreservation.ResultsThe defined, xeno-, and feeder-free culture system provided a robust means to generate high-quality hPSCs with chromosomal stability limited to early passages. Inductive cues introduced during the first week of differentiation had a substantial effect on lineage specification, cell survival, and even mature RPE properties. Derivative RPE formed functional epithelial monolayers with mature tight junctions and expression of RPE genes and proteins, as well as phagocytosis and key growth factor secretion capacity after 9 weeks of maturation on inserts. Efficient LESC differentiation led to cell populations expressing LESC markers such as p40/p63α by day 24. Finally, we established xeno-free cryobanking protocols for pluripotent hPSCs, hPSC-RPE cells, and hPSC-LESCs, and demonstrated successful recovery after thawing.ConclusionsWe propose methods for efficient and scalable, directed differentiation of high-quality RPE cells and LESCs. The two clinically relevant cell types are generated with simple inductive modification of the same basal method, followed by adherent culture, passaging, and cryobanking.

Generation of Functional Lentoid Bodies from Human-Induced Pluripotent Stem Cells

Generation of Functional Lentoid Bodies from Human Induced Pluripotent Stem Cells Derived from Urinary Cells.

Efficient Generation of Lens Progenitor Cells from Cataract Patient-Specific Induced Pluripotent Stem Cells

Generation of Human Lens Epithelial‐Like Cells from Patient‐Specific Induced Pluripotent Stem Cells

Opacification of lentoid bodies derived from human induced pluripotent stem cells is accelerated by hydrogen peroxide and involves protein aggregation.

Inducing Pluripotency for Disease Modeling, Drug Development and Craniofacial Applications.

Reprogramming of Ipscs to NPCEC-like Cells by Biomimetic Scaffolds for Zonular Fiber Reconstruction

Modeling Congenital Cataract in Vitro Using Patient-Specific Induced Pluripotent Stem Cells

Xeno- and feeder-free differentiation of human pluripotent stem cells to two distinct ocular epithelial cell types using simple modifications of one method

Abnormal morphology and function in retinal ganglion cells derived from patients-specific iPSCs generated from individuals with Leber's hereditary optic neuropathy.

Lens Regeneration in Situ Using Hescs-Derived Cells —similar to Natural Lens

Development and challenge of human lentoid bodies generation

Generation of Induced Pluripotent Stem Cell Line (Zzui0012-A) from a Patient with Fahr's Disease Caused by a Novel Mutation in SLC20A2 Gene.

Human Induced Pluripotent Stem Cell for Modeling Cardiovascular Diseases.

Eye Lens Organoids Made Simple: Characterization of a New Three-Dimensional Organoid Model for Lens Development and Pathology

Postponement of the opacification of lentoid bodies derived from human induced pluripotent stem cells after lanosterol treatment—the first use of the lens aging model in vitro in cataract drug screening

Eye lens organoids going simple: characterization of a new 3-dimensional organoid model for lens development and pathology

Lens regeneration using endogenous stem cells with gain of visual function

Development of a potent embryonic chick lens model for studying congenital cataracts in vivo

Generation of Induced Pluripotent Stem Cells Using Recombinant Proteins.

Use of Human Pluripotent Stem Cells to Define Initiating Molecular Mechanisms of Cataract for Anti-Cataract Drug Discovery